Pier 88 Investment Partners LLC Iovance Biotherapeutics, Inc. Transaction History
Pier 88 Investment Partners LLC
- $76.1 Million
- Q3 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 44,180 shares of IOVA stock, worth $359,625. This represents 0.54% of its overall portfolio holdings.
Number of Shares
44,180
Previous 58,580
24.58%
Holding current value
$359,625
Previous $469,000
11.73%
% of portfolio
0.54%
Previous 0.54%
Shares
12 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
241MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$222 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$217 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$195 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$173 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$107 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.28B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...